Literature DB >> 2305914

End state renal disease among Native Americans, 1983-86.

J M Newman1, A A Marfin, P W Eggers, S D Helgerson.   

Abstract

We used data reported to Medicare from 1983 through 1986 to determine the incidence of end-stage renal disease (ESRD) among Native Americans and Whites in the United States. The 1,075 Native American cases represented an annual incidence, age-adjusted to the White population, of 269 per million, 2.8 times the rate for Whites. Fifty-six percent of Native American cases and 27 percent of the White cases were attributed to diabetes, indicating that ESRD is a major problem. Diabetes control provides the greatest opportunity for prevention.

Entities:  

Mesh:

Year:  1990        PMID: 2305914      PMCID: PMC1404694          DOI: 10.2105/ajph.80.3.318

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Trends in the US end-stage renal disease population: 1973-1983.

Authors:  S J Rosansky; P W Eggers
Journal:  Am J Kidney Dis       Date:  1987-02       Impact factor: 8.860

2.  The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85.

Authors:  R Ferguson; C E Grim; T J Opgenorth
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

3.  Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.

Authors:  R G Nelson; J M Newman; W C Knowler; M L Sievers; C L Kunzelman; D J Pettitt; C D Moffett; S M Teutsch; P H Bennett
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

Review 4.  Primary prevention of diabetes mellitus.

Authors:  J Tuomilehto; E Wolf
Journal:  Diabetes Care       Date:  1987 Mar-Apr       Impact factor: 19.112

5.  Diabetes in American Indians: a growing problem.

Authors:  D M Gohdes
Journal:  Diabetes Care       Date:  1986 Nov-Dec       Impact factor: 19.112

  5 in total
  8 in total

1.  Regional differences in dialysis care and mortality among American Indians and Alaska Natives.

Authors:  Yoshio N Hall; Stacey E Jolly; Ping Xu; Christine K Abrass; Dedra Buchwald; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 10.121

2.  Adaptation of the Dartmouth COOP Charts for use among American Indian people with diabetes.

Authors:  S S Gilliland; A J Willmer; R McCalman; S M Davis; M E Hickey; G E Perez; C L Owen; J S Carter
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

3.  Survival on dialysis among American Indians and Alaska Natives with diabetes in the United States, 1995-2010.

Authors:  Nilka Ríos Burrows; Pyone Cho; Kai McKeever Bullard; Andrew S Narva; Paul W Eggers
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

4.  Racial misclassification of American Indians: its effect on injury rates in Oregon, 1989 through 1990.

Authors:  J R Sugarman; R Soderberg; J E Gordon; F P Rivara
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

5.  Incidence and causes of end-stage renal disease among Aboriginal children and young adults.

Authors:  Susan M Samuel; Bethany J Foster; Brenda R Hemmelgarn; Alberto Nettel-Aguirre; Lynden Crowshoe; R Todd Alexander; Andrea Soo; Marcello A Tonelli
Journal:  CMAJ       Date:  2012-08-27       Impact factor: 8.262

6.  Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan.

Authors:  R F Dyck; L Tan
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

7.  Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.

Authors:  R G Nelson; W C Knowler; D R McCance; M L Sievers; D J Pettitt; M A Charles; R L Hanson; Q Z Liu; P H Bennett
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

Review 8.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.